Before reading this article, please click "Follow", which is not only convenient for you to discuss and share, but also can bring you a different sense of participation, thank you for your support.
Title: Siemens Healthineers showcases medical technology innovation to help Chinese patients access more accurate medical services
For the sixth consecutive year at the CIIE, Siemens Healthineers has demonstrated remarkable innovations. In the medical device and health care exhibition area, they launched a number of revolutionary new products to empower the precise diagnosis and treatment of tumors and cardiovascular and cerebrovascular diseases.
The world's first ultra-high-performance whole-body 3T magnetic resonance imaging MAGNETOM Cima.X1 introduces a breakthrough gradient system to improve clinical imaging performance, especially in the field of oncology and neurology. This will bring a huge breakthrough in the diagnosis and treatment of early-stage tumors.
Siemens Healthineers' world's first "walking" CT SOMATOM On.site2 can be pushed into patient rooms at will, improving the efficiency of first aid while providing double radiation protection to ensure patient safety.
The 178 picosecond TOF PET/CT Biograph Vision.X3 achieves the ultimate performance and provides more accurate diagnosis and treatment plans for patients with advanced cancer.
ACUSON AcuNav Volume 4D ICE Catheter4 can help doctors perform structural heart disease interventional procedures, reduce complications, and improve the success rate of surgery.
The world's first quantum spectroscopy angiography system, ARTIS icono ceiling5, has achieved a number of breakthroughs in precision, low radiation and intelligent adjustment, providing a new era of cancer treatment.
CIIE has become a powerful platform for Siemens Healthineers to showcase its innovative achievements, making many innovative products popular products. Siemens Healthineers will actively participate in the development of medical technology in China and contribute to China's medical industry.